safety of glp-1 receptor agonists Top Balance Weight Loss Efficacy, GLP-1 Agonists For Obesity In
Description
For you as someone considering or using these medications, the practical takeaway is straightforward

Tapering protocols that reduce the shock of discontinuation

202402AA310005) Kunming University of Science and Technology Joint Special Project (No

Common signs of NAION include: Sudden, unilateral painless loss of vision Visual field defect (usually altitudinal) Blurred vision Dyschromatopsia (new onset impairment or loss of color vision) Relative afferent pupillary defect Optic disc swelling with or without hemorrhages A patient starting a GLP-1RAespecially if they have diabetes or age-related macular degeneration should have an in-person, comprehensive, dilated eye examination either within the 12 months prior to starting therapy or a baseline examination within one month of initiating therapy
32260-8/asset/b3e92579-8c29-4267-895b-56d26c1d4c0b/main.assets/gr3_lrg.jpg)
This is a placebo-controlled study with a duration of 72 weeks (83)

Aim for 7-9 hours of quality sleep nightly
